Abstract
In the United States, the seroprevalence rate for hepatitis E virus (HEV) is ≈ 20%. This study examined HEV seroprevalence in persons with and without chronic liver disease. Our data indicate that HEV seropositivity is high in patients with chronic liver disease and that HEV seroprevalence increases significantly with age.
Cite
CITATION STYLE
APA
Atiq, M., Shire, N. J., Barrett, A., Rouster, S. D., Sherman, K. E., & Shata, M. T. (2009). Hepatitis E virus antibodies in patients with chronic liver disease. Emerging Infectious Diseases, 15(3), 479–481. https://doi.org/10.3201/eid1503.080740
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free